Unmasking Undiagnosed Asthma and COPD Improves Health
Identifying and treating people with previously undiagnosed asthma or COPD led to improved respiratory symptoms, quality of life, and reduced healthcare visits in the year after diagnosis.
Tag: inhaled nitric oxide
All
Latest
All
Latest
Inhaled Nitric Oxide Delivery: Past, Present, and Future
Inhaled nitric oxide has been utilized as a pulmonary vasodilator for over 20 years and research is ongoing to uncover the usefulness of iNO in several lung diseases and disorders.Â
All
Latest
Phase 3 Study Underway for Inhaled Nitric Oxide Treatment of Interstitial Lung Disease
The first patient has been enrolled in Bellerophon's Phase 3 study of pulsed inhaled nitric oxide to treat fibrotic interstitial lung disease.
Products 2020: Gas Delivery & Humidification (NO, O2)
The latest devices in humidification, inhaled nitric oxide, and oxygen therapy from Caire, NeoTech, Vero Biotech, Vapotherm, Precision Medical, and RapidOxygen.
Read More
Clinical Trials Testing Inhaled Nitric Oxide as COVID-19 Therapy
This clinical trial will monitor patients with mild to moderate cases of COVID-19 to see how they respond to inhaled nitric oxide as a treatment.
Read More
INOpulse Inhaled Nitric Oxide Device Submitted as COVID-19 Therapy
Bellerophon submits new drug application for INOpulse inhaled nitric oxide therapy to treat COVID-19 patients receiving oxygen.
Read More
Home Care: First COVID-19 Patient with Pulmonary Hypertension Treated with New iNO System
The patient was treated under an emergency IND filed by a qualified Investigator and approved by the US FDA, according to the manufacturer Vero Biotech.
Read More
Phase 3 Trial to Test Inhaled Nitric Oxide for Pulmonary Fibrosis-related Pulmonary Hypertension
Bellerophon Therapeutics will soon initiate a Phase 3 trial for its INOpulse inhaled nitric oxide therapy for the treatment of pulmonary hypertension associated with pulmonary fibrosis.
Read More
Genosyl Inhaled Nitric Oxide Delivery System Approved by FDA
The FDA has approved the Genosyl inhaled nitric oxide (iNO) gas delivery system, a tankless, portable iNO system that eliminates the need for large nitric oxide tanks.
Read More
Circassia Acquires US Rights to AirNOvent
Circassia Pharmaceuticals is acquiring exclusive commercialization rights to nitric oxide product AirNOvent in the US and China from from AIT Therapeutics.
Read More
Nitric Oxide Effective against Mycobacterium abscessus
Inhaled nitric oxide had significant antibacterial activity against Mycobacterium abscessus (M. abscessus), which can infect the airways of patients with cystic fibrosis.
Read More
RT Awareness and Preferences Regarding Pulmonary Hypertension Treatment
RTs may find it difficult to choose between available inhaled pulmonary vasodilators (IPVs)—inhaled nitric oxide or nebulized epoprostenol—to treat pulmonary hypertension.
Read MoreInhaled Nitric Oxide May Not Improve Survival of Preterm Infants
Preterm infants born younger than 29 weeks’ gestational age who were treated for pulmonary hypoplasia with inhaled nitric oxide did not have an increased chance of in-hospital survival, according to findings published in JAMA...
Read More
Fluorescent Sensor Developed To Detect Nitric Oxide
A new compound developed by researchers from Spain allows for the detection of nitric oxide by fluorescence.
Read More
Hypoxia, Nitric Oxide Worsen Sickle Cell Disease
Low levels of both oxygen and nitric oxide appear to have an unfortunate synergy for patients with sickle cell disease, researchers report.
Read More